34.01
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Volume | 0 |
|
|||||
News | (1) | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
REGENXBIO Inc | RGNX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
34.01 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 18.69 - 46.46 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 34.01 | USD |
REGENXBIO Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 1.47B | 43.23M | 28.36M | $ 470.35M | $ 77.94M | 2.91 | 16.60 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | - | 159.30k | 1.40% |
REGENXBIO News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RGNX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 32.89 | 35.73 | 32.59 | 34.50 | 355,177 | 1.12 | 3.41% |
1 Month | 28.48 | 35.73 | 26.0301 | 32.14 | 376,783 | 5.53 | 19.42% |
3 Months | 21.70 | 35.73 | 18.69 | 26.07 | 416,129 | 12.31 | 56.73% |
6 Months | 26.68 | 35.73 | 18.69 | 26.90 | 412,939 | 7.33 | 27.47% |
1 Year | 28.715 | 46.46 | 18.69 | 30.55 | 429,435 | 5.30 | 18.44% |
3 Years | 38.93 | 54.97 | 18.69 | 35.29 | 422,822 | -4.92 | -12.64% |
5 Years | 20.65 | 85.10 | 18.69 | 41.27 | 451,264 | 13.36 | 64.7% |
REGENXBIO Description
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). |